Dipeptidyl peptidase-IV is a potential molecular biomarker in diabetic kidney disease. (Q53181586)

12 May 2018

title

Dipeptidyl peptidase-IV is a potential molecular biomarker in diabetic kidney disease. (English)

1 reference

12 May 2018

0 references

Ai-li Sun

1

1 reference

12 May 2018

Jing-ti Deng

2

1 reference

12 May 2018

Guang-ju Guan

3

1 reference

12 May 2018

Shi-hong Chen

4

1 reference

12 May 2018

Yuan-tao Liu

5

1 reference

12 May 2018

Jing Cheng

6

1 reference

12 May 2018

Zhen-wei Li

7

1 reference

12 May 2018

Xiang-hua Zhuang

8

1 reference

12 May 2018

Fu-dun Sun

9

1 reference

12 May 2018

Hao-ping Deng

10

1 reference

12 May 2018

language of work or name

English

0 references

publication date

2 March 2012

1 reference

12 May 2018

Diabetes and Vascular Disease Research

published in

1 reference

12 May 2018

volume

9

1 reference

12 May 2018

page(s)

301-308

1 reference

12 May 2018

issue

4

1 reference

12 May 2018

Identification and proteomic profiling of exosomes in human urine

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1479164111434318

Dipeptidyl peptidase-IV expression and activity in human glomerular endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164111434318

Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164111434318

Solid phase immunoassay for high molecular weight alkaline phosphatase in human sera using a specific monoclonal antibody.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164111434318

Rapid isolation of urinary exosomal biomarkers using a nanomembrane ultrafiltration concentrator

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164111434318

Nucleic acids within urinary exosomes/microvesicles are potential biomarkers for renal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164111434318

Large-scale proteomics and phosphoproteomics of urinary exosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164111434318

Candidate biomarkers in exosome-like vesicles purified from rat and mouse urine samples.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164111434318

CD26/dipeptidyl peptidase IV enhances expression of topoisomerase II alpha and sensitivity to apoptosis induced by topoisomerase II inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164111434318

CD26 regulates p38 mitogen-activated protein kinase-dependent phosphorylation of integrin beta1, adhesion to extracellular matrix, and tumorigenicity of T-anaplastic large cell lymphoma Karpas 299.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164111434318

Regulation of p38 phosphorylation and topoisomerase IIalpha expression in the B-cell lymphoma line Jiyoye by CD26/dipeptidyl peptidase IV is associated with enhanced in vitro and in vivo sensitivity to doxorubicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164111434318

The role of microparticles in inflammation and thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164111434318

Interrelationship of dipeptidyl peptidase IV (DPP4) with the development of diabetes, dyslipidaemia and nephropathy: a streptozotocin-induced model using wild-type and DPP4-deficient rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164111434318

Hyperglycaemia increases dipeptidyl peptidase IV activity in diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164111434318

Plasma dipeptidyl peptidase-IV activity in patients with type-2 diabetes mellitus correlates positively with HbAlc levels, but is not acutely affected by food intake.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164111434318

Decreased dipeptidyl peptidase-IV activity and glucagon-like peptide-1(7-36)amide degradation in type 2 diabetic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164111434318

Dipeptidyl peptidase IV and incident diabetes: the Atherosclerosis Risk in Communities (ARIC) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164111434318

21 January 2018

Identifiers

DOI

10.1177/1479164111434318

1 reference

12 May 2018

PubMed ID

22388283

1 reference

12 May 2018